Sertraline 50 mg tablet
Public data on sertraline from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
NADAC per unit, monthly
SERTRALINE HCL 50 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.05058 |
| 2014-02 | 0.05552 |
| 2014-05 | 0.05456 |
| 2014-08 | 0.05427 |
| 2014-11 | 0.05479 |
| 2015-02 | 0.05186 |
| 2015-05 | 0.05260 |
| 2015-08 | 0.05800 |
| 2015-11 | 0.05573 |
| 2016-02 | 0.05228 |
| 2016-05 | 0.05698 |
| 2016-08 | 0.04997 |
| 2016-11 | 0.04888 |
| 2017-02 | 0.05211 |
| 2017-05 | 0.04747 |
| 2017-08 | 0.04706 |
| 2017-11 | 0.04774 |
| 2018-02 | 0.04733 |
| 2018-05 | 0.04495 |
| 2018-08 | 0.04382 |
| 2018-11 | 0.04294 |
| 2019-02 | 0.04684 |
| 2019-05 | 0.04093 |
| 2019-08 | 0.04444 |
| 2019-11 | 0.04612 |
| 2020-02 | 0.04262 |
| 2020-05 | 0.04286 |
| 2020-08 | 0.06817 |
| 2020-11 | 0.04920 |
| 2021-02 | 0.05474 |
| 2021-05 | 0.04863 |
| 2021-08 | 0.04881 |
| 2021-11 | 0.04459 |
| 2022-02 | 0.04157 |
| 2022-05 | 0.04452 |
| 2022-08 | 0.04358 |
| 2022-11 | 0.04188 |
| 2023-02 | 0.03919 |
| 2023-05 | 0.04450 |
| 2023-08 | 0.04589 |
| 2023-11 | 0.04057 |
| 2024-02 | 0.04184 |
| 2024-05 | 0.03586 |
| 2024-08 | 0.03551 |
| 2024-11 | 0.03440 |
| 2025-02 | 0.03488 |
| 2025-05 | 0.03656 |
| 2025-08 | 0.03606 |
| 2025-11 | 0.03671 |
| 2026-02 | 0.03753 |
| 2026-05 | 0.03453 |
| 2026-08 | 0.03456 |
| 2026-11 | 0.03484 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning sertraline
openFDA enforcement records, by year reported.
| 2025 | 1 |
| 2024 | 1 |
| 2018 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 2 |
7 records since 2012. A record is one product or lot, not one recall event. Combination products that contain sertraline are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention sertraline
15 GxRadar articles cite or discuss this drug.
What pharmacies paid for six generic antidepressants, 2013 to 2026
Federal NADAC data for sertraline, escitalopram, citalopram, fluoxetine, trazodone and duloxetine show three very different price paths since 2013, and FDA approval records help explain them.
How to look up a drug on DailyMed
DailyMed is the National Library of Medicine's free archive of drug labels as companies submit them to FDA. How to search it by name or NDC, find inactive ingredients and imprints, and tell the leaflets apart.
Medication Guides and patient package inserts
What 21 CFR Part 208 requires, when a pharmacy must hand over a Medication Guide, how patient package inserts differ, and where FDA's one-page replacement proposal stands.
Boxed warnings, FDA's most prominent label warning, explained
What 21 CFR 201.57 requires of a boxed warning, how many prescription labels carry one (about a third, by two counts 14 years apart), and why a generic's box matches the brand's.
How to compare pharmacy cash prices for a generic prescription
A 2014 phone survey found one generic antibiotic priced from $5 to $229 in a single county. How to compare cash quotes by phone, and how to read them against NADAC.
Pediatric exclusivity and the six months it adds before generics
A brand company that studies its drug in children at FDA's written request can win six more months of protection from generics. How the 1997 incentive works, what it attaches to, and what FDA's own lists show.